Results 11 to 20 of about 4,127 (206)

Aptamers in Immunotherapy [PDF]

open access: yesHuman Gene Therapy, 2008
Numerous nucleic acid ligands, also termed decoys or aptamer, have been developed during the past 20 years that can bind to and inhibit the activity of many proteins. The concept that nucleic acid ligands could modulate the activity of proteins emerged from basic science studies of viruses and early work in the field of gene therapy.
Claudia M, Dollins   +2 more
openaire   +2 more sources

DNA-Based Molecular Engineering of the Cell Membrane

open access: yesMembranes, 2022
The cell membrane serves as a barrier and gatekeeper to regulate the cellular transportation of substances and information. It plays a significant role in protecting the cell from the extracellular environment, maintaining intracellular homeostasis, and ...
Xiaodong Li   +5 more
doaj   +1 more source

Development of DNA Aptamers to Visualize Release of Mycobacterial Membrane-Derived Extracellular Vesicles in Infected Macrophages

open access: yesPharmaceuticals, 2021
Extracellular vesicles (EVs) have emerged into a novel vaccine platform, a biomarker and a nano-carrier for approved drugs. Their accurate detection and visualization are central to their utility in varied biomedical fields.
Soonjyoti Das   +9 more
doaj   +1 more source

Computational design of single-stranded DNA hairpin aptamers immobilized on a biosensor substrate

open access: yesScientific Reports, 2021
Aptamer interactions with a surface of attachment are central to the design and performance of aptamer-based biosensors. We have developed a computational modeling approach to study different system designs—including different aptamer-attachment ends ...
Iman Jeddi, Leonor Saiz
doaj   +1 more source

Aptamers in analytics [PDF]

open access: yesThe Analyst, 2016
Nucleic acid aptamers are promising alternatives to antibodies in analytics.
Ilgu, Muslum, Nilsen-Hamilton, Marit
openaire   +3 more sources

Engineering constructed of high selectivity dexamethasone aptamer based on truncation and mutation technology

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Various biosensors based on aptamers are currently the most popular rapid detection approaches, but the performance of these sensors is closely related to the affinity of aptamers.
Yadi Qin   +5 more
doaj   +1 more source

Aptamers as therapeutics [PDF]

open access: yesNature Reviews Drug Discovery, 2010
Nucleic acid aptamers can be selected from pools of random-sequence oligonucleotides to bind a wide range of biomedically relevant proteins with affinities and specificities that are comparable to antibodies. Aptamers exhibit significant advantages relative to protein therapeutics in terms of size, synthetic accessibility and modification by medicinal ...
Keefe, Anthony D.   +2 more
openaire   +2 more sources

Aptamer-iRNAs as Therapeutics for Cancer Treatment

open access: yesPharmaceuticals, 2018
Aptamers are single-stranded oligonucleotides (ssDNA or ssRNA) that bind and recognize their targets with high affinity and specificity due to their complex tertiary structure.
Mario M. Soldevilla   +3 more
doaj   +1 more source

Enhancement of in vivo targeting properties of ErbB2 aptamer by chemical modification.

open access: yesPLoS ONE, 2023
Aptamers have great potential for diagnostics and therapeutics due to high specificity to target molecules. However, studies have shown that aptamers are rapidly distributed and excreted from blood circulation due to nuclease degradation.
Jun Young Park   +4 more
doaj   +1 more source

Aptamers as Therapeutics [PDF]

open access: yesAnnual Review of Pharmacology and Toxicology, 2017
Aptamers are single-stranded nucleic acid molecules that bind to and inhibit proteins and are commonly produced by systematic evolution of ligands by exponential enrichment (SELEX). Aptamers undergo extensive pharmacological revision, which alters affinity, specificity, and therapeutic half-life, tailoring each drug for a specific clinical need.
Shahid M, Nimjee   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy